Register entry

AkaRx, Inc.

Data as of · How to read this entry

Registered sites
0
Active NDC listings
2
Live patents
2
Exclusivities
2
Countries
0
Catalogue

Drug listings by form and route

2

2 active NDC listings: 2 human prescription drug. By marketing category: NDA 2.

Dosage formNDCs
granule1
tablet, film coated1
RouteNDCs
oral2
Labeller name on the listingNDCs
akarx, inc.2
Exclusivity

Patents and exclusivities

2
PatentProductCoversExpiry
7638536DOPTELET, DOPTELET SPRINKLEavatrombopag maleatesubstance, productJul 2027
ProductExclusivityUntil
DOPTELETAVATROMBOPAG MALEATEODE-548 Orphan drugJul 2032
DOPTELET SPRINKLEAVATROMBOPAG MALEATEODE-548 Orphan drugJul 2032
Catalogue

Marketed products

2
BrandGeneric nameForm / routeNDC
DOPTELETavatrombopag maleatetablet, film coated, oral71369-020NDA
Doptelet Sprinkleavatrombopaggranule, oral71369-010NDA
Enquiry

Common questions

Is AkaRx, Inc. FDA approved?
AkaRx, Inc. holds no registered establishment of its own; 2 drug products are listed under its name in the National Drug Code Directory, made at sites registered to other firms.
What drugs does AkaRx, Inc. make?
2 products are listed under AkaRx, Inc. in the openFDA NDC Directory, most often as granule; tablet, film coated. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.